The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of trametinib in patients with advanced solid tumors harboring genomic alterations in the MAPK pathway: Results from the BELIEVE trial (NCCH1901).
 
Hideyuki Hayashi
No Relationships to Disclose
 
Junichi Matsubara
Honoraria - DAIICHI SANKYO COMPANY, LIMITED
 
Hiroshi Nishihara
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Incyte Japan; MSD; Novartis; Pfizer
Consulting or Advisory Role - NLAC; Secom Medical System
Research Funding - Chugai Pharma; Mitsubishi Space Software Inc; Sanofi/Aventis
 
Eishi Baba
Honoraria - Amgen; Asahi kasei pharm; Astellas Pharma; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck; MSD; Novartis; Ono Pharmaceutical; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Ichiro Kinoshita
Honoraria - Bayer; Chugai Pharma; Guardant Health; Konica Minolta; MSD; Novartis; Pfizer; Takeda
Research Funding - Daiich Sankyo; Eisai; Konica Minolta
 
Hirokazu Takami
Research Funding - Astellas Co., Ltd.
 
Naohiro Nishida
No Relationships to Disclose
 
Masahiro Tabata
No Relationships to Disclose
 
Toru Mukohara
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Kirin; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Eisai; Micin
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst)
 
Masanobu Takahashi
Speakers' Bureau - Bristol-Myers Squibb Japan; Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hirotsugu Kenmotsu
Honoraria - Amgen; AstraZeneca; Bayer Yakuhin; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi-Sankyo; Guardant Health; Kyowa Hakko Kirin; Lilly; Merck; MSD K.K; Nihonkayaku; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Lilly Japan (Inst); Loxo (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Satoshi Nishiwaki
No Relationships to Disclose
 
Yayoi Ando
No Relationships to Disclose
 
Kuniko Sunami
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Guardant Health; Illumina; Konica Minolta Precision Medicine; Lilly; Novartis; Pfizer; Riken Genesis; Sysmex
Research Funding - Sysmex
 
Tatsunori Shimoi
No Relationships to Disclose
 
Noboru Yamamoto
Honoraria - Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai
Consulting or Advisory Role - Boehringer Ingelheim; Chugai Pharma; CMIC; Eisai; Healios; Merck; Mitsubishi Tanabe; Noile-Immune Biotech, Inc; Rakuten Medical Japan
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Carna Biosciences (Inst); Chiome Bioscience (I); Chugai Pharma (Inst); CMIC (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genmab/Seattle Genetics (Inst); GlaxoSmithKline (Inst); InventisBio (Inst); Janssen (Inst); Kaken Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (I); Pfizer (Inst); Rakuten Medical (Inst); Shionogi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Toray Industries (Inst)